ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) saw a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 16,382 shares, a drop of 47.3% from the July 15th total of 31,101 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average trading volume of 53,359 shares, the days-to-cover ratio is presently 0.3 days.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research report on Monday, July 6th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.
Get Our Latest Analysis on ALPS Group Inc Ordinary Share
ALPS Group Inc Ordinary Share Price Performance
ALPS Group Inc Ordinary Share Company Profile
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Featured Articles
- Five stocks we like better than ALPS Group Inc Ordinary Share
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
